Revisiting Barriers to Clinical Trials Accrual
Open Access
- 6 October 2020
- journal article
- editorial
- Published by Oxford University Press (OUP) in JNCI: Journal of the National Cancer Institute
- Vol. 113 (3) , 219-220
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Patient-Centered Cancer Drug Development: Clinical Trials, Regulatory Approval, and Value AssessmentAmerican Society of Clinical Oncology Educational Book, 2019
- Systematic Review and Meta-Analysis of the Magnitude of Structural, Clinical, and Physician and Patient Barriers to Cancer Clinical Trial ParticipationJNCI: Journal of the National Cancer Institute, 2019
- Evaluating patient and stakeholder engagement in research: moving from theory to practiceJournal of Comparative Effectiveness Research, 2015
- The National Cancer Institute–American Society of Clinical Oncology Cancer Trial Accrual Symposium: Summary and RecommendationsJournal of Oncology Practice, 2013
- Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA StatementJournal of Clinical Epidemiology, 2009
- Accrual to cancer clinical trials: Directions from the research literatureSocial Science & Medicine, 1991